Balyasny Asset Management
NUTX

Balyasny Asset Management’s Nutex Health NUTX Stock Holding History

Balyasny Asset Management’s Portfolio NUTX Stock Details NUTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,510
Closed -$239K – 3361
2026
Q1 		$239K Buy
+2,510
New +$308K ﹤0.01% 2639
2023
Q3 		– Sell
-9,124
Closed -$577K – 2575
2023
Q2 		$577K Buy
9,124
+7,935
+667% +$681K ﹤0.01% 1805
2023
Q1 		$180K Buy
+1,189
New +$241K ﹤0.01% 2243

Other funds holding NUTX

PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Winmill & Co Walpole, New Hampshire $452M AUM 56.84% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

Balyasny Asset Management's NUTX Position: Q2 2026 in Review

Balyasny Asset Management sold out of Nutex Health (NUTX) in Q2 2026, closing a stake of 2,510 shares — an estimated $239K sold.

Balyasny Asset Management first reported a position in NUTX in Q1 2023 and held it in 3 quarters. The position peaked at $577K in Q2 2023. 154 funds tracked by Wall St. Rank hold NUTX as of Q2 2026.

  • Balyasny Asset Management reported no remaining Nutex Health position as of Q2 2026 after selling out during the quarter.
  • Balyasny Asset Management sold 2,510 Nutex Health shares in Q2 2026, an estimated $239K.
  • Balyasny Asset Management first reported a position in Nutex Health in Q1 2023 and held it in 3 quarters.
  • Balyasny Asset Management's Nutex Health position peaked at $577K in Q2 2023.
  • 154 funds tracked by Wall St. Rank held Nutex Health as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.